Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 21%
Sell 7%
Strong Sell 0%

Bulls say

AMN Healthcare Services reported segment revenue of $454.7 million, which, despite being down 15% year-over-year, surpassed estimates and was supported by strong daily revenue per traveler and an increase in the average number of travelers on assignment. The labor disruption revenue significantly exceeded projections, with $62 million generated in the fourth quarter alone, contributing to an optimistic revenue outlook for 2024. Additionally, adjusted EBITDA of $75.1 million exceeded expectations, indicating operational stability amidst revenue fluctuations, while the company's guidance for the first quarter suggests a positive trend that reflects a potential recovery in the healthcare staffing market.

Bears say

AMN Healthcare Services Inc is facing a challenging financial outlook, highlighted by a significant decline in international nurse revenue, which dropped by $49 million in 2024 and is expected to persist into 2025. The company anticipates a substantial year-over-year drop of 22% to 25% in revenue from its key Nurse and Allied Solutions segment, which is critical as it generates the majority of AMN's revenue. Additionally, with the decline in demand for contract labor and potential economic pressures driving nurses back into full-time clinical positions, revenue and profit estimates may prove overly optimistic, compounding the negative sentiment surrounding the stock.

AMN has been analyzed by 14 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 21% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 14 analysts, AMN has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.